Skip to Main Content

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Accept
RTI International
  • About
    • Office Locations
    • Executive Leadership
    • Corporate Governance
    • Partner with Us
      • U.S. Government
      • Clients and Funding Agencies
      • Industry and Commercial Clients
      • Foundations and Associations
      • Bilateral Agencies and Multilateral Banks
      • Universities and Academic Research Institutions
      • Suppliers and Small Businesses
    • Commitment to Quality
      • RTI's Client Listening Program
    • Ethics and Human Research Protection
    • Living Our Mission
    • Open Science Initiative
    • Veteran Opportunities at RTI

    About

  • Practice Areas
    • Health
      • Public Health and Well-Being
      • Health Care Transformation
      • Behavioral Health
      • Health Behavior Change
      • Precision Medicine
      • RTI Health Solutions (RTI-HS)
      • Health Equity
      • Community & Workplace Health
      • Public Health Economics
      • Child and Adolescent Research and Evaluation Program
      • RTI Health Advance
    • Transformative Research Unit for Equity​
      • Equity Capacity Building Hub
      • Social and Economic Justice Research Collaborative
      • Narrative Research and Community Engagement Lab
    • Education and Workforce Development
      • Early Childhood
      • K-12 Education
      • Postsecondary Education
      • Career and Adult Education and Workforce Development
      • Education Policy, Systems, and Governance
      • Education Research Methodologies
      • Education Technologies
      • International Education
    • International Development
      • Climate Change
      • Energy for Development
      • Environment
      • Global Food Security, Agriculture, and Nutrition
      • Global Health
      • International Education
      • Monitoring, Evaluation, Research, Learning, and Adapting (MERLA)
      • Youth and Economic Opportunity
      • Water, Sanitation, and Hygiene (WASH)
      • RTI Center for Global Noncommunicable Diseases
      • RTI Center for Governance
      • RTI Center for Thriving Children
    • Climate Change
      • Clean Energy Technology and Renewables
      • Climate Finance
      • Climate Justice and Equity
      • Climate Planning, Preparedness and Resilience
      • Climate Policy
      • Climate Vulnerability, Adaptation, and Mitigation
      • Economic Impacts of Climate Change
    • Water
      • Food-Energy-Water Nexus
      • Water Quality
      • WASH (Water, Sanitation, Hygiene)
      • Water Resources Management
    • Energy Research
      • Carbon Capture and Utilization
      • Biomass Conversion
      • Natural Gas
      • Energy Efficiency
      • Industrial Water
      • Syngas Processing
    • Environmental Sciences
      • Air Quality
      • RTI Center for Water Resources
      • Urban Sustainability
      • Toxics
      • Building Resiliency in the FEW Nexus
      • Climate Change Sciences and Analysis
      • Environmental Policy
      • Environmental Justice
      • Sustainable Materials & Waste Management Solutions
    • Justice Research and Policy
      • RTI Center for Community Safety and Crime Prevention
      • RTI Center for Policing Research and Investigative Science
      • Child Well-Being and Family Strengthening
      • RTI Center for Forensic Sciences
      • Evidence-Based Strategies to Reduce Firearm Violence
    • Food Security and Agriculture
      • Food Security and Food Assistance
      • Nutrition, Physical Activity, & Obesity
      • Food Safety
      • Food Systems and Policy Analysis
      • Food Loss and Waste Research
      • Market Systems Strengthening
      • Global Food Security, Agriculture, and Nutrition
      • Climate-Smart Agriculture
      • Agricultural Innovation
    • Innovation Ecosystems
      • Innovation Advising
      • Innovation for Economic Growth
      • Innovation for Emerging and Developing Economies
      • Innovation for Organizations
      • Research, Technology, and Innovation Policy
      • Technology Acceleration
    • Military Support
      • Military Behavioral Health
      • Military Health and Human Performance
      • Military Sexual Assault, Harassment, and Domestic Violence Prevention
      • Wearable Sensor Technologies
      • Military Health System Transformation
      • North Carolina Center for Optimizing Military Performance

    Practice Areas

  • Services + Capabilities
    • Surveys and Data Collection
      • Survey Design
      • Instrument Development
      • Survey Methodologies
      • Data Collection
      • Establishment Surveys
      • Health Registries
      • Data Analysis and Reporting
      • Research Operations Center
    • Statistics and Data Science
      • Survey Statistics
      • Environmental Statistics
      • Coordinating Centers for Multisite Studies
      • Analysis and Design of Complex Data
      • Biostatistics
      • RTI Center for Data Science
    • Evaluation, Assessment and Analysis
      • Evaluation Design and Execution
      • Advanced Qualitative, Quantitative, and Mixed Methods
      • Evaluation, Monitoring, and Assessment
      • Economic Analysis
      • Evaluating Communication Interventions and Campaigns
      • Evidence Synthesis for Policy and Practice
      • Risk Assessment and Prediction
    • Program Design and Implementation
      • Systems Strengthening and Scaling
      • Capacity Assessment and Building
      • Policy Reform Support
      • Curriculum and Teacher Professional Development
      • Interventions and Prevention Programs
      • Implementation Science
    • Digital Solutions for Social Impact
      • Human-Centered Design of Digital Solutions
      • Digital Product Development
      • Digital Communication Campaigns
      • Digital Data Analytics
    • Research Technologies
      • Survey Technologies
      • Data Management and Decision Support Systems
      • Geospatial Science, Technology, and Visualization
      • ICT for Limited-Resource Settings
      • Mobile Applications
      • Web Applications
      • Bioinformatics
      • Interactive Computing
    • Drug Discovery and Development
      • Medicinal Chemistry
      • Molecular Design and Cheminformatics
      • Behavioral Pharmacology
      • Drug Metabolism and Pharmacokinetics (DMPK)
      • In Vitro Pharmacology, Bioassay Development, and High-Throughput Screening (HTS)
      • Isotope Labeling
      • Regulatory Consulting and Support for Medical Products
    • Analytical Laboratory Sciences
      • Bioanalytical and Toxicology Research
      • Forensic Sciences
      • Physicochemical Characterizations
      • Metabolomics
      • Proficiency Testing and Reference Materials
      • Microbiology
      • Analytical Chemistry and Pharmaceutics
    • Engineering & Technology R&D
      • Biomedical Technologies
      • Decarbonization Sciences
      • Environmental Exposure & Protection
      • Materials & Environment
      • Sustainable Energy Solutions

    Services + Capabilities

  • Impact
    • Newsroom
    • Insights Blog
    • Events
    • Publications
    • RTI Press
      • About the RTI Press
      • Instructions for Authors
      • RTI Press Collections
    • Projects
    • Global Reach
      • Asia
      • Eastern Europe and Central Asia
      • RTI International India
      • Africa
      • Middle East and North Africa (MENA)
      • Latin America and the Caribbean (LAC)

    Impact

  • Experts
    • Our Experts
    • In-Depth With Our Experts
    • Related News
    • Experts In the Media
    • RTI Fellow Program

    Experts

  • Emerging Issues
    • COVID-19 Research
    • Artificial Intelligence
    • Global Health Security
    • Cannabis Research
    • Opioid Research
      • Interventions for Opioid Use Disorders
      • Preventing Opioid Misuse and Overdose
      • Treating Opioid Use Disorders
    • Policing Research and Investigative Science
    • Drone Research and Application
    • E-cigarette Research
    • Zika Virus Research
    • Integrated Governance

    Emerging Issues

  • Global Reach
  • Insights Blog
  • Newsroom
  • RTI Press
  • Publications
  • Partner With Us
  • Careers
  • Facebook IconTwitter IconInstagram IconYouTube IconLinkedin Icon
Impact

The SCHIELD Implant: Preventing Unintended Pregnancy and HIV with One Product

  • Home
  • Impact
  • SCHIELD Implant for HIV and Unintended Pregnancy Prevention

A collaborative effort to create a new reproductive health implant based on women’s needs and innovative medical technologies

Reproductive health concerns have profound effects on both individual lives and societies. Globally, 89 million unintended pregnancies, nearly 870,000 new HIV infections, and millions more other sexually transmitted infections occur among women each year.

In the global fight against the HIV pandemic, a key milestone was the 2012 introduction of oral PrEP, a daily pill that, if taken correctly and consistently, prevents HIV transmission. Oral PrEP remains the only drug for this purpose, and it isn’t easy for everyone, especially younger women, to adhere to the daily routine without occasional missed doses.  

Contraception, meanwhile, is available in many forms, but each has its own pros and cons. Women have different characteristics that they prefer. Some women want a long-acting method, others want one that’s quickly reversible, and still others value discretion above all other qualities. The users’ priorities are as diverse as their circumstances.

RTI’s work in global health and gender equity has led us to work on many HIV prevention projects, especially in sub-Saharan Africa, where the risk of HIV infection is greatest. In 2013, with funding from USAID, and later in 2016, with additional funds from the Bill and Melinda Gates Foundation, we began working on an implantable long-acting HIV prevention device. Known as TIP, this ongoing program merges our experience in HIV prevention with our decades of work in medical device innovation.

SCHIELD has successfully expanded the achievements of TIP. Launched in 2017, the USAID-funded SCHIELD project aims to create a multipurpose prevention technology (MPT) implantable product that provides both contraception and HIV prevention. This MPT implant offers a combination of attributes that surpass existing delivery systems: user independence, biodegradation, long-term protection, and discretion of use. It adds to women’s options in that it is removable in the event of a serious adverse reaction or a woman’s desire for return to fertility. As a biodegradable product, there is no need for device removal after depletion of the drug, eliminating the necessity for follow-up visits to a health care clinic, a known burden on end-users and health care providers (HCPs).

Over the past year, the SCHIELD team made critical advancements in optimizing the drug formulations and device configuration. In in vitro studies, we achieved sustained release of both antiretroviral (ARV) and hormonal contraceptive with a constant release rate over 12 months. In collaboration with the Magee-Womens Research Institute and Foundation at the University of Pittsburgh, we completed our first in vivo preclinical study and demonstrated a drug-delivery duration of three months. Current goals include extending the implant therapeutic duration to six or even 12 months. Results from these studies are critical to the continued advancement and optimization of the MPT implant.

To optimize future uptake of this technology by women and HCPs globally, we have also incorporated end-user feedback into early stage of product development. Working with partners in South Africa and Zimbabwe, we have conducted interviews and focus groups of health care providers and potential end users, exploring their preferences for the implants along with potential future marketing strategies.

The way I see it, SCHIELD implant is the best compared to other implants available. Actually, it's excellent because it's 2-in-1 and it does not have to be removed. This means less pain.

Early-stage feedback from end users is crucial to the implant’s future success. The findings from our qualitative studies help inform the research chemists and engineers who are combining their expertise to create the implant. Some of its features include:

  • Consistent dosing of both contraceptive and HIV preventive drugs
  • Effective for at least 1 year
  • Removable if desired or needed, but also biodegradable, to avoid the pain of removal or cost and time associated with a clinic visit
  • Flexible when palpating, so health providers can find and remove it easily, but discreet for the user

End users in these focus groups who had given birth before preferred the longest possible duration offered, which was 3 years. However, we learned that women who have never had children tended to prefer a device that would be effective for 1 to 2 years. Because they also face a higher risk of HIV infection, they may be the ideal audience for our implant.

I think that, it’s ok not to have it removed because if I think of the removal, I think of the pain. And that pain is what sometimes makes a woman avoid going for removal.

Future avenues of research include whether similar implants could be used to treat cancer, other infectious diseases, and opioid use disorder. Our hope is that the implants we develop will impact end-users by providing a new option for contraception and HIV prevention, seamlessly integrated into women’s lives, making it easier for them to plan pregnancies and protect themselves from HIV, even in high-risk circumstances.

Share

Highlights

  • SCHIELD involves a multidisciplinary team that merges our experience in HIV prevention with our decades of work in medical device innovation.
  • Interviews and focus groups with health care providers and potential end users in sub-Saharan Africa helped inform our design of the implant.
  • We recently conducted our first in vivo study and are now working to extend the duration of the implant to six or even 12 months.

Clients

  • U.S. Agency for International Development (USAID)

Partners

  • Setshaba Research Centre (SRC)
  • Pangaea Zimbabwe AIDS Trust (PZAT)
  • PATH
  • University of North Carolina at Chapel Hill
  • Centers for Disease Control and Prevention (CDC)
  • Magee Women’s Research Institute/University of Pittsburgh

Our Experts

Leah Johnson Senior Director of Biomedical Technologies
Ellen Luecke
Ellen Luecke Senior Project Manager

Practice Areas

Gender Equity and Disparity Health Behavior Change Public Health and Well-Being Global Health

Services

Drug Metabolism and Pharmacokinetics (DMPK) Drug Discovery and Development

Countries

Zimbabwe South Africa
65 Years
Partner With Us
  • US Government
  • Commercial
  • Foundations & Associations
  • Multilateral Donors
  • Universities
  • Suppliers
Site
  • Privacy Policy
  • Security Policy
  • Site Map
  • Terms of Use
  • Accessibility
  • Contact Us
Contact Us
Facebook Icon Twitter Icon Instagram Icon YouTube Icon Linkedin Icon
delivering the promise of science
for global good
RTI International Logo
RTI Health Solutions RTI Innovation Advisors RTI Health Advance

© 2023 RTI International. RTI International is a trade name of Research Triangle Institute. RTI and the RTI logo are U.S. registered trademarks of Research Triangle Institute.